DURHAM, N.C.–(BUSINESS WIRE)–Target RWE, a leading real-world evidence (RWE) solutions company for the pharmaceutical and biotech industries based in Durham, North Carolina, today announced the acquisition of NoviSci, Inc., a software analytics and services company whose innovative technologies enable the visualization and analysis of health data using modern epidemiological methods and sound scientific principles. The acquisition significantly broadens Target RWE’s data analytics capabilities and will enable the company to meet increasing demand for high quality evidence from real-world data.

Related to this acquisition, Amgen Inc., a strategic investor in and collaborator with NoviSci, has also made a strategic…